Tetsumei Urano

Title: Tetsumei Urano: Innovator in Preterm Delivery Solutions

Introduction

Tetsumei Urano is a notable inventor based in Shizuoka, Japan. He has made significant contributions to the field of obstetrics through his innovative research and patenting efforts. His work focuses on addressing the critical issue of preterm delivery and miscarriage in pregnant women.

Latest Patents

Tetsumei Urano holds a patent for a therapeutic agent aimed at preventing preterm delivery or abortion using plasminogen activator inhibitor-1. This patent describes a method for diagnosing the risk of preterm delivery or miscarriage in pregnant women. The method involves measuring the activity or level of plasminogen activator inhibitor-1 in plasma isolated from a pregnant woman. If the activity or level is found to be lower than that of a normal pregnant woman, it indicates a risk for preterm delivery or miscarriage. The patent also includes the administration of plasminogen activator inhibitor-1 to those identified at risk, along with a kit for diagnosing the degree of risk.

Career Highlights

Throughout his career, Tetsumei Urano has been associated with prestigious institutions such as Hamamatsu University School of Medicine and the National University Corporation Hamamatsu University School of Medicine. His work in these institutions has allowed him to advance his research and contribute to the medical community.

Collaborations

Tetsumei Urano has collaborated with notable colleagues, including Naohiro Kanayama and Kazuo Umemura. These collaborations have further enriched his research and development efforts in the field of obstetrics.

Conclusion

Tetsumei Urano's innovative work in the area of preterm delivery prevention highlights his commitment to improving maternal and fetal health. His contributions through patenting and collaboration with esteemed colleagues underscore the importance of research in addressing critical health issues.